The RNA binding motif protein 3 (RBM3) has been identified as a promising prognostic and potentially treatment predictive biomarker in several major cancer forms e.g. breast, ovarian, prostate, bladder and colorectal cancer as well as malignant melanoma [6-11]. The gene discussed is RBM3; the disease is colorectal cancer.